Fowler J F
Department of Medicine, Division of Dermatology, University of Louisville School of Medicine, Louisville, Kentucky, USA.
J Cutan Med Surg. 2001 May-Jun;5(3):201-5. doi: 10.1007/s102270000020. Epub 2001 May 2.
Irritant and allergic hand dermatitis is difficult to control in individuals who are unable to avoid causative exposures. Effectiveness of "protective" creams has been poor.
To determine if hand dermatitis, primarily of an occupational nature, could be improved by the use of a newly developed moisturizing cream containing Quaternium-18-Bentonite.
Adult male and female subjects with chronic hand dermatitis felt to be either allergic, irritant, or combined in nature, after a 2-week observation period, were given the study cream for routine application. At 2, 4, and 8 weeks, the investigator and the subject evaluated the skin parameters, including redness, scaling, fissuring, blistering, and pruritus, on a numerical scale. A global evaluation was also performed. Photographs were taken at each visit. Use of topical corticosteroids was recorded. No systemic therapies other than antihistamines were allowed.
Thirty-seven subjects were enrolled in the study and 33 completed it. The physician's and the subject's initial global evaluations averaged 6.0 and 5.8, respectively (0-10 scale). The final scores were 2.9 and 2.8, respectively, an improvement of 50% (p < 0.001). Topical corticosteroid usage was reduced in 29 of 33 subjects. Fifteen of 35 had a final score of 0-2, indicating complete or almost complete clearing. Only 10, including 2 of the dropouts, failed to show improvement. No adverse effects were noted.
This moisturizing cream significantly improved chronic hand dermatitis in a majority of individuals with previously uncontrolled dermatitis despite continuing in their regular occupation.
对于无法避免接触致病源的个体,刺激性和过敏性手部皮炎难以控制。“防护”霜的效果不佳。
确定使用新开发的含季铵盐-18-膨润土的保湿霜是否能改善主要为职业性的手部皮炎。
在为期2周的观察期后,将患有慢性手部皮炎、被认为是过敏性、刺激性或混合性的成年男性和女性受试者给予研究用霜进行常规涂抹。在第2、4和8周时,研究者和受试者以数字评分法评估皮肤参数,包括发红、脱屑、皲裂、水疱和瘙痒。还进行了整体评估。每次就诊时均拍照。记录局部用皮质类固醇的使用情况。除抗组胺药外,不允许使用其他全身治疗方法。
37名受试者纳入研究,33名完成研究。医生和受试者最初的整体评估平均分分别为6.0和5.8(0-10分制)。最终分数分别为2.9和2.8,改善了50%(p<0.001)。33名受试者中有29名局部用皮质类固醇的使用减少。35名受试者中有15名最终评分为0-2分,表明完全或几乎完全消退。只有10名受试者(包括2名退出者)未显示改善。未观察到不良反应。
这种保湿霜在大多数先前手部皮炎未得到控制的个体中显著改善了慢性手部皮炎,尽管他们仍继续从事常规职业。